- Home
- MTC vs DERM Comparison
MTC vs DERM Comparison
Compare MTC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- DERM
- Stock Information
- Founded
- MTC 2015
- DERM 2014
- Country
- MTC Hong Kong
- DERM United States
- Employees
- MTC N/A
- DERM N/A
- Industry
- MTC Computer Software: Prepackaged Software
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- MTC Technology
- DERM Health Care
- Exchange
- MTC Nasdaq
- DERM Nasdaq
- Market Cap
- MTC 152.7M
- DERM 124.4M
- IPO Year
- MTC 2019
- DERM 2021
- Fundamental
- Price
- MTC $0.36
- DERM $5.48
- Analyst Decision
- MTC
- DERM Strong Buy
- Analyst Count
- MTC 0
- DERM 3
- Target Price
- MTC N/A
- DERM $9.50
- AVG Volume (30 Days)
- MTC 1.5M
- DERM 158.9K
- Earning Date
- MTC 11-19-2024
- DERM 11-19-2024
- Dividend Yield
- MTC N/A
- DERM N/A
- EPS Growth
- MTC N/A
- DERM N/A
- EPS
- MTC 0.47
- DERM 0.04
- Revenue
- MTC $869,935.00
- DERM $77,681,000.00
- Revenue This Year
- MTC N/A
- DERM N/A
- Revenue Next Year
- MTC N/A
- DERM $50.57
- P/E Ratio
- MTC $1.59
- DERM $128.80
- Revenue Growth
- MTC N/A
- DERM 26.38
- 52 Week Low
- MTC $0.24
- DERM $2.85
- 52 Week High
- MTC $12.90
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- MTC 46.96
- DERM 46.70
- Support Level
- MTC $0.36
- DERM $5.43
- Resistance Level
- MTC $0.43
- DERM $5.82
- Average True Range (ATR)
- MTC 0.03
- DERM 0.47
- MACD
- MTC -0.00
- DERM -0.05
- Stochastic Oscillator
- MTC 22.37
- DERM 38.95
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, MMBD Advisory and HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.